Description

REGENOVUE Fine Plus with Lidocaine

REGENOVUE Fine Plus is a professional cross-linked hyaluronic acid dermal filler with lidocaine. It is supplied as one sterile 1.1ml prefilled syringe and is designed for qualified professional assessment of suitable superficial facial-line applications.

The formulation contains 24mg/ml of cross-linked hyaluronic acid and 0.3% lidocaine. The incorporated lidocaine is intended to improve patient comfort during administration. REGENOVUE Fine Plus is manufactured in South Korea by NeoGenesis Co., Ltd.

REGENOVUE Fine Plus must only be purchased and administered by appropriately qualified, trained and insured healthcare or aesthetic professionals.

What Is REGENOVUE Fine Plus Used For?

REGENOVUE Fine Plus is the small-molecule, lidocaine-containing filler within the REGENOVUE Plus range. Product information positions it for professional use in the upper dermis, where a fine filler profile may be appropriate for selected superficial lines.

Depending on individual anatomy, tissue characteristics and clinical assessment, a qualified practitioner may consider REGENOVUE Fine Plus for suitable fine lines, superficial wrinkles, perioral lines, forehead lines, neck lines or selected delicate facial areas.

These examples are product-positioning information only. The treating professional must determine whether the product, treatment area, placement depth, quantity and technique are appropriate after an individual consultation and risk assessment.

REGENOVUE Fine Plus Product Specifications

• Product: REGENOVUE Fine Plus with Lidocaine
• Product type: Cross-linked hyaluronic acid dermal filler
• Hyaluronic acid concentration: 24mg/ml
• Lidocaine concentration: 0.3% or 3mg/ml
• Formulation: Monophasic cross-linked hyaluronic acid gel
• Presentation: One 1.1ml prefilled syringe
• Recommended professional positioning: Upper dermis
• Needles: One 30G and one 27G sterile needle, subject to supplied packaging
• Manufacturer: NeoGenesis Co., Ltd.
• Country of manufacture: South Korea
• Storage: 2°C to 25°C, protected from direct sunlight
• Use: Professional aesthetic use only

Always check the physical carton to confirm the exact syringe volume, accessory configuration, batch number, expiry date and current manufacturer instructions before treatment or publication.

Key Features of REGENOVUE Fine Plus

• Professional cross-linked hyaluronic acid dermal filler
• Contains 24mg/ml hyaluronic acid
• Contains 0.3% lidocaine
• Fine gel profile for suitable superficial professional applications
• Supplied as a sterile 1.1ml prefilled syringe
• Part of the REGENOVUE Plus lidocaine-containing range
• Manufactured by NeoGenesis in South Korea
• Requires individual patient assessment and informed consent

Cross-Linked Hyaluronic Acid

Hyaluronic acid is naturally present within the human body and contributes to tissue hydration and structure. In a dermal filler, cross-linking creates a gel that can provide temporary physical support when correctly placed in suitable tissue by a qualified professional.

REGENOVUE Fine Plus has a finer gel profile than REGENOVUE Deep Plus and REGENOVUE Sub-Q Plus. It should be selected when the practitioner considers a fine filler appropriate for the treatment objective, rather than for areas requiring deeper support or structural contouring.

Hyaluronic acid fillers are not permanent implants. Treatment response and visible duration can vary according to placement, quantity, treatment area, individual metabolism, lifestyle and tissue characteristics. No particular result or duration can be guaranteed.

REGENOVUE Fine Plus Compared with Other REGENOVUE Fillers

• REGENOVUE Fine Plus: Fine gel profile for suitable upper-dermis applications.
• REGENOVUE Deep Plus: Medium gel profile for suitable lower-dermis and upper-subcutaneous applications.
• REGENOVUE Sub-Q Plus: Larger-particle gel profile for suitable deep-support applications.

The “Plus” designation identifies REGENOVUE products containing lidocaine. Product selection should be guided by individual anatomy, intended treatment area, tissue depth, required support and professional clinical judgement.

Professional Consultation and Patient Assessment

Before using REGENOVUE Fine Plus, the practitioner should review the patient’s medical history, allergies, medication, previous aesthetic treatments, skin condition and treatment expectations. The intended treatment area should be assessed for infection, inflammation, irritation, broken skin or another factor that may make treatment unsuitable.

Patients should receive clear information about the planned treatment, realistic limitations, possible adverse effects, aftercare and alternative options. Informed consent should be obtained before treatment. Product traceability information, including batch number and expiry date, should be documented in the patient record.

Important Safety Information

REGENOVUE Fine Plus must never be injected into a blood vessel. Accidental intravascular administration of any dermal filler can cause serious complications, including vascular occlusion, tissue damage, skin necrosis, visual impairment, blindness or stroke.

Administration requires detailed facial-anatomy knowledge, aseptic technique and the ability to recognise and manage complications promptly. Qualified practitioners should maintain appropriate emergency procedures, equipment and referral arrangements.

Do not use REGENOVUE Fine Plus in patients with known hypersensitivity to hyaluronic acid, lidocaine, amide-type local anaesthetics or another product component. Do not treat areas affected by active infection, inflammation, irritation, broken skin, untreated skin disease or an active cold-sore outbreak.

Pregnancy, breastfeeding, immune conditions, anticoagulant medication, bleeding disorders, significant allergies, recent treatment in the same area and a history of problematic scarring require careful professional consideration. Review the supplied manufacturer instructions before use.

Possible Treatment Reactions

Temporary injection-site reactions may include redness, swelling, tenderness, bruising, itching, firmness, discomfort or discolouration. Less common complications can be serious and may require urgent professional assessment.

Patients should receive written aftercare information and clear contact instructions. Unexpected or increasing pain, skin blanching, unusual colour changes, visual symptoms or neurological symptoms require immediate professional attention.

Storage, Handling and Traceability

Store REGENOVUE Fine Plus at 2°C to 25°C and protect it from direct sunlight unless the supplied carton states otherwise. Do not use the product if its sterile packaging is damaged, the expiry date has passed, the gel appears abnormal or storage conditions cannot be verified.

The prefilled syringe and supplied needles are single-use devices. Do not reuse or resterilise them. Dispose of used equipment and unused product through appropriate clinical and sharps-waste procedures.

Order REGENOVUE Fine Plus

REGENOVUE Fine Plus with Lidocaine is available from The Clinic Vault for eligible professional purchasers. Customers are responsible for ensuring that they have the qualifications, training, insurance and legal authority required to purchase and administer injectable aesthetic products.

Explore our professional aesthetic product collection or review available REGENOVUE product information before procurement.

Professional-use notice: This page provides product-identification and professional-procurement information only. It does not replace supplied manufacturer instructions, accredited clinical training, local regulations, professional judgement or an individual patient assessment.